New Frontiers in Gene Editing
Gene editing is rapidly progressing from being a research/ screening tool to one that promises important applications downstream in drug development, cell therapy and bioprocessing. • Genome editing (e.g., CRISPRs technology to replace defective DNA with “good” DNA) is now a new trend in 2016. The engineered editing system makes use of an enzyme that nicks together DNA with a piece of small RNA that guides the tool to where researchers want to introduce cuts or other changes in the genome.
- Nucleic Acid based Editing: RNA Editing
- RNAi Engineering
- Editing of m-RNA
- Cas-9 application in RNA Modification
- Single Cell Cancer Genomics
- Genetics and genomics of cancer immunity and immunotherapy
- Intra-tumoural and inter-tumour heterogeneity
- ctDNA
Related Conference of New Frontiers in Gene Editing
June 18-19, 2026
16th International Conference on Human Genetics and Genetic Diseases
Singapore City, Singapore
June 18-19, 2026
19th International Conference on Genomics & Pharmacogenomics
Singapore City, Singapore
September 24-25, 2026
19th World Congress on Advances in Stem Cell Research and Regenerative Medicine
Paris, France
Heidelberg Germany
1st EMBL Conference Cancer Genomics Heidelberg Germany
1st to 4th November 2015
San Francisco CA United States of America
Genomic Sample Prep and Biomarker Assay Development DNA RNA Extraction NGS Assays Liquid Biopsy Antibody Validation More San Francisco United States of America
7th to 9th March 2016
San Francisco CA United States of America
Clinical NGS Diagnostics Translating Genomic Data to the Standard of Care San Francisco United States of America
7th to 9th March 2016
San Francisco CA United States of America
Genomics Sequencing Data Integration Analysis and Visualization San Francisco United States of America
10th to 11th March 2016
San Francisco CA United States of America
New Fronteirs in Gene Editing San Francisco United States of America
10th to 11th March 2016
London United Kingdom
HPLC Congress 2016 London United Kingdom
24th to 25th March 2016
Vienna Austria
2016 Genetics and Genomics Conference Vienna Austria
1st to 3rd June 2016
San Diego California United States of America
Genome Editing and Engineering Conference San Diego United States of America
18th to 19th February 2016
Breckenridge Colorado United States of America
Keystone Symposia Stem Cells and Cancer Breckenridge United States of America
6th to 10th March 2016
San Francisco CA United States of America
Clinical NGS Diagnostics Translating Genomic Data to the Standard of Care San Francisco United States of America
7th to 9th March 2016
Singapore
Human Genomics Singapore Singapore
8th to 10th November 2015
Kuala Lumpur Malaysia
The Probiotics Congress Asia Kuala Lumpur Malaysia
29th February to 1st March 2016
Heidelberg Germany
1st EMBL Conference Cancer Genomics Heidelberg Germany
1st to 4th November 2015
San Francisco CA United States of America
Genomic Sample Prep and Biomarker Assay Development DNA RNA Extraction NGS Assays Liquid Biopsy Antibody Validation More San Francisco United States of America
7th to 9th March 2016
San Francisco CA United States of America
Clinical NGS Diagnostics Translating Genomic Data to the Standard of Care San Francisco United States of America
7th to 9th March 2016
San Francisco CA United States of America
Genomics Sequencing Data Integration Analysis and Visualization San Francisco United States of America
10th to 11th March 2016
San Francisco CA United States of America
New Fronteirs in Gene Editing San Francisco United States of America
10th to 11th March 2016
London United Kingdom
HPLC Congress 2016 London United Kingdom
24th to 25th March 2016
Vienna Austria
2016 Genetics and Genomics Conference Vienna Austria
1st to 3rd June 2016
San Diego California United States of America
Genome Editing and Engineering Conference San Diego United States of America
18th to 19th February 2016
Breckenridge Colorado United States of America
Keystone Symposia Stem Cells and Cancer Breckenridge United States of America
6th to 10th March 2016
San Francisco CA United States of America
Clinical NGS Diagnostics Translating Genomic Data to the Standard of Care San Francisco United States of America
7th to 9th March 2016
Singapore
Human Genomics Singapore Singapore
8th to 10th November 2015
Kuala Lumpur Malaysia
The Probiotics Congress Asia Kuala Lumpur Malaysia
29th February to 1st March 2016
New Frontiers in Gene Editing Conference Speakers
Recommended Sessions
Related Journals
Are you interested in
- 3D Bioprinting, Organ Fabrication & Bioartificial Tissues - Stem Cell 2026 (Netherlands)
- Advanced Gene Therapeutics - Cell Signaling 2026 (France)
- Aging Biology, Longevity Science & Cellular Rejuvenation - Stem Cell 2026 (Netherlands)
- Animal Genetics - Genome 2026 (Singapore)
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Bioengineering Therapeutics - Cell Signaling 2026 (France)
- Bioinformatics and Computational Biology - Genome 2026 (Singapore)
- Bioinformatics, AI Models & Predictive Regeneration - Stem Cell 2026 (Netherlands)
- Biomarkers and Microarrays - Genome 2026 (Singapore)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer Genomics - Genome 2026 (Singapore)
- Cancer Stem Cells & Targeted Therapeutics - Stem Cell 2026 (Netherlands)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiac, Vascular & Musculoskeletal Regeneration - Stem Cell 2026 (Netherlands)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Cell Biology - Cell Signaling 2026 (France)
- Cell Culture and Bioprocessing - Cell Signaling 2026 (France)
- Cell Cycle/Proliferation - Cell Signaling 2026 (France)
- Cell Death and Viability - Cell Signaling 2026 (France)
- Cell Science and Stem Cell Research - Cell Signaling 2026 (France)
- Cellular Signaling - Cell Signaling 2026 (France)
- Cellular Therapies - Cell Signaling 2026 (France)
- Clinical genomics - Genome 2026 (Singapore)
- Clinical Translation of Stem Cell Therapies - Stem Cell 2026 (Netherlands)
- Clinical Trials and Research in Stem Cell in Cancer Therapy - Cell Signaling 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- Commercialization, Biobanking & Industry Innovations - Stem Cell 2026 (Netherlands)
- Comparative Genomics - Genome 2026 (Singapore)
- Epidermis Stem Cell & Cancer Epidemiology - Cell Signaling 2026 (France)
- Epigenomics and Epigenetics - Genome 2026 (Singapore)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Ethical, Regulatory & Quality Control Frameworks - Stem Cell 2026 (Netherlands)
- Exosomes, Extracellular Vesicles & Cell-Free Therapeutics - Stem Cell 2026 (Netherlands)
- Functional Genomics - Genome 2026 (Singapore)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Gene Editing and Genetic Engineering - Genome 2026 (Singapore)
- Gene Editing, CRISPR Therapies & Regenerative Genomics - Stem Cell 2026 (Netherlands)
- Genetic Disorder - Genome 2026 (Singapore)
- Genomic Instability - Genome 2026 (Singapore)
- Genomic Medicine - Genome 2026 (Singapore)
- Human Gene Therapy - Cell Signaling 2026 (France)
- Immunotherapy - Cell Signaling 2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Microbial Genomics - Genome 2026 (Singapore)
- Molecular Epigenetics - Cell Signaling 2026 (France)
- Nano-Therapy - Cell Signaling 2026 (France)
- Nanotechnology in Stem Cell - Cell Signaling 2026 (France)
- Next generation sequencing - Genome 2026 (Singapore)
- Nutrigenomics - Genome 2026 (Singapore)
- Personalized and Regenerative Medicine - Genome 2026 (Singapore)
- Pharmacogenomics - Genome 2026 (Singapore)
- Plant Genomics and Molecular Pharming - Genome 2026 (Singapore)
- Regeneration in Neurodegenerative & Spinal Cord Disorders - Stem Cell 2026 (Netherlands)
- Regenerative Approaches in Diabetes & Metabolic Disorders - Stem Cell 2026 (Netherlands)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Immunology & Immune Modulation - Stem Cell 2026 (Netherlands)
- Regenerative Medicine - Cell Signaling 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Regulatory and Ethical Issues of Therapies. - Cell Signaling 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cell Engineering & Cellular Reprogramming - Stem Cell 2026 (Netherlands)
- Stem Cell in Drug Development - Cell Signaling 2026 (France)
- Stem Cell Therapies - Cell Signaling 2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)
- Structural Genomics - Genome 2026 (Singapore)
- Tissue Engineering, Biomaterials & Smart Scaffolds - Stem Cell 2026 (Netherlands)
- Trends in Genomics and Pharmacogenomics - Genome 2026 (Singapore)